Hepatitis-associated aplastic anemia: successful outcome following immunosuppressive therapy

Indian J Gastroenterol. 2005 Jul-Aug;24(4):175-6.

Abstract

Hepatitis-associated aplastic anemia is an uncommon variant seen in young, previously healthy individuals. The pancytopenia follows hepatitis by a few weeks and is usually severe and prolonged. Bone marrow transplantation remains the cornerstone of therapy. However, immunosuppressive therapy has been found to be effective. We report an 8-year-old girl who had non-A, B, C and E hepatitis-associated severe aplastic anemia. She became transfusion-independent and had consistent, albeit incomplete recovery after immunosuppressive therapy with antithymocyte globulin and cyclosporine.

Publication types

  • Case Reports

MeSH terms

  • Anemia, Aplastic / virology*
  • Antilymphocyte Serum / therapeutic use
  • Child
  • Drug Therapy, Combination
  • Female
  • Hepatitis, Viral, Human / complications*
  • Humans
  • Immunosuppressive Agents / therapeutic use

Substances

  • Antilymphocyte Serum
  • Immunosuppressive Agents